false
OasisLMS
zh-CN,zh-TW,en,fr,de,ja,ko,pt,es,th,vi
Catalog
View Only-Mile-High Genetics: Adult Medical Geneti ...
Mile-High Genetics: Adult Medical Genetics Cases
Mile-High Genetics: Adult Medical Genetics Cases
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
In this edition of the ACMG Genomics Case Conference for Adult Genetics and Genomics, Dr. Matt Taylor is presenting and discussing a few cases that were seen in the Adult Medical Genetics Clinic at the University of Colorado. The first case discussed is about a teenager who had a family history of hypertrophic cardiomyopathy. Genetic testing confirmed the presence of a pathogenic variant in the TNNI3 gene. The decision was made to implant a defibrillator in the teenager, and it ultimately saved their life. The second case is about a 36-year-old patient who had a history of long QT syndrome. Genetic testing revealed a pathogenic variant in the Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) gene. The patient's diagnosis was changed from long QT syndrome to CPVT. The third case is about a 41-year-old woman with mild intellectual disability and congenital anomalies. Microarray testing revealed a deletion on chromosome 2 and identified several genes within the deleted region. This provided new information about the patient's condition. The final case is about a woman with a history of breast cancer and fibroadenomas. Genetic testing did not identify a hereditary cancer variant but did reveal a variant of uncertain significance in the neurofibromatosis type 1 gene. Further evaluation of the patient's history and family history revealed that the neurofibromatosis variant may not be relevant. The patient's case is now being explored for other potential genetic causes of her condition.
Asset Subtitle
Hosted by the University of Colorado
Keywords
ACMG Genomics Case Conference
University of Colorado
hypertrophic cardiomyopathy
TNNI3 gene
long QT syndrome
CPVT gene
chromosome 2 deletion
microarray testing
neurofibromatosis type 1 gene
×